Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy

Clinical Cancer Research

Volumn 3, Issue 9, 1997, Pages 1507-1518

  Foxall, Peta J D ^a,d   Singer, Julian M ^b   Hartley, Janet M ^b   Neild, Guy H ^a   Lapsley, Marta ^c   Nicholson, Jeremy K ^d   Souhami, Robert L ^b  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPIC ACID; DACTINOMYCIN; DOXORUBICIN; DRUG METABOLITE; ETOPOSIDE; GLUCOSE; GLUTARIC ACID; GLYCINE; HISTIDINE; IFOSFAMIDE; LACTIC ACID; MESNA; METHYLENE BLUE; RETINOL BINDING PROTEIN; TRIMETHYLAMINE OXIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOFT TISSUE SARCOMA; URINALYSIS; URINARY EXCRETION;

ADULT; AMINO ACIDS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BRAIN DISEASES; DICARBOXYLIC ACIDS; HUMANS; IFOSFAMIDE; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY MEDULLA; MAGNETIC RESONANCE SPECTROSCOPY; MESNA; METHYLENE BLUE; MOLECULAR WEIGHT; NEOPLASMS; PROTONS; RETINOL-BINDING PROTEINS; URINALYSIS;

EID: 0030879036     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brade, W. P., Herdich, K., and Varini, M. Ifosfamide: pharmacology, safety and therapeutic potential. Cancer Treat. Rev., 12: 1-47, 1985.
2. Goren, M. P., Wright, R. K., Horowitz, M. E., and Pratt, C. B. Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. Cancer Treat. Rep., 71: 127-139, 1987.
3. Skinner, R., Pearson, A. D. J., Price, L., Coulthard, M. G., and Craft, A. W. Nephrotoxicity after ifosfamide. Arch. Dis. Child 65: 732-738, 1990.
4. Skinner, R., Sharkey, I. M., Pearson, A. D. J., and Craft, A. W. Ifosfamide, mesna and nephrotoxicity in children. J. Clin Oncol., 11: 173-190, 1993.
5. Meanwell, C. A., Blake, A. E., Kelly, K. A., Honigsberger, L., and Blackledge, G. Prediction of ifosfamide/mesna-associated encephalopathy. Eur. J. Cancer Clin. Oncol., 22: 815-819, 1986.
6. Cerney, T., and Kupfer, A. The enigma of ifosfamide encephalopathy. Ann. Oncol., 3: 679-681, 1992.
7. Kupfer, A., Aeschilmann, C., Wermuth, B., and Cerney, T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet, 343: 763-764, 1994.
8. Videen, J. S., and Ross, B. D. Proton nuclear magnetic resonance urinalysis: coming of age. Kidney Int., 46 (Suppl.): S122-S128, 1994.
9. Nicholson, J. K., and Wilson, I. D. High resolution proton NMR spectroscopy of biological fluids. Prog. NMR Spectrom., 21: 449-501, 1989.
10. Iies, R. A., and Chalmers, R. A. Nuclear magnetic resonance spectroscopy in the study of inborn errors of metabolism. Clin Sci 74: 1-10, 1988.
11. Foxall, P. J. D., Bending, M. R., Gartland, K. P. R., and Nicholson, J. K. Acute renal failure following accidental cutaneous absorption of phenol: application of NMR urinalysis to monitor the disease process. Hum. Toxicol., 9: 491-496, 1989.
12. Le Moyec, L., Pruna, A., Eugene, M., Bedrossian, J., Idatte, J. M., Huneau, J. F., and Tome, D. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron, 65: 433-439, 1993.
13. Foxall, P. J. D., Mellotte, G. J., Bending, M. R., Lindon, J. C., and Nicholson, J. K. NMR spectroscopy as a novel approach to monitor renal transplant function. Kidney Int., 42: 234-245, 1993.
14. Gartland, K. P. R., Bonner, F. W., and Nicholson, J. K. Investigations into the biochemical effects of region-specific nephrotoxins. Mol. Pharmacol., 35: 242-250, 1989.
15. Anthony, M. L., Gartland, K. P. R., Beddell, C. R., Lindon, J. C., and Nicholson, J. K. Studies of the biochemical toxicology of uranyl nitrate in the rat. Arch. Toxicol., 68: 43-53, 1994.
16. Anthony, M. L., Gartland, K. P. R., Beddell, C. R., Lindon, J. C., and Nicholson, J. K. Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damage. Arch. Toxicol., 66: 525-537, 1992.
17. 2H NMR spectroscopic studies on the metabolism and biochemical effects of 2-bromoethanamine in the rat. Biochem. Pharmacol., 49: 1349-1359, 1995.
18. 31P nuclear magnetic resonance spectroscopy. J. Pharmacol. Exp. Ther., 260: 1133-1144, 1992.
19. Foxall, P. J. D., Lenz, E. M., Lindon, J. C., Neild, G. H., Wilson, I. D., and Nicholson, J. K. NMR and HPLC-NMR studies on the toxicity and metabolism of ifosfamide. Ther. Drug Monit., 18: 51-58, 1996.
20. Topping, M. D., Forster, H. W., Dolman, C., Luczynska, C. M., and Bernard, A. M. Measurement of urinary retinol-binding protein by enzyme-linked immunosorbant assay, and its application to detection of tubular proteinuria. Clin. Chem. 32: 1863-1866, 1986.
21. Bales, J. R., Higham, D. P., Howe, I., Nicholson, J. K., and Sadler, P. J. Use of high resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin. Chem., 30: 426-432, 1984.
22. Foxall, P. J. D., Parkinson, J. A., Sadler, I. H., Lindon, J. C., and Nicholson, J. K. Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. J. Pharmacol. Biomed. Anal., 11: 21-31, 1993.
23. 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal. Biochem., 220: 284-296, 1994.
24. Hartley, J. M., Hansen, L., Harland, S. J., Nicholson, P. W., Pasinin, F., and Souhami, R. L. Metabolism of ifosfamide during 3 day infusion. Br. J. Cancer, 69: 931-936, 1994.
25. Ormstad, K., Orrenius, T., Uehara, N., Pohl, J., Stekar, J., and Brock, N. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. Cancer Res., 43: 333-338, 1983.
26. Lapsley, M., Norden, A. G. W., Akers, K., Wrong, O. M., and Scheinman, S. J. Sensitive assays for retinol binding protein and β-2-glycoprotein-1: new reference ranges for adults and children. In: Proceedings of the XVI International Congress of Clinical Chemistry, p. 482, 1996.
27. Kriz, W., and Bankir, L. A standard nomenclature for structures of the kidney. Kidney Int., 33: 1-7, 1988.
28. Brodehl, J. Fanconi syndrome. In: S. Cameron, A. M. Davison, J. P. Grünfeld, and D. Kerr (eds.), Oxford Textbook of Clinical Nephrology, Vol. 1, pp. 723-740. New York: Oxford University Press, 1992.
29. Silbernagl, S. Tubular transport of amino acids and small peptides. In: E. E. Windhager (ed.), Renal Physiology, Vol. II, pp. 1937-1976. New York: Oxford University Press, 1992.
30. Nissim, I., and Weinberg, J. M. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int., 49: 684-695, 1996.
31. Roch-Ramel, F., Besseghir, K., and Murer, H. Renal excretion and tubular transport of organic anions and cations. In: E. E. Windhager (ed.), Renal Physiology, Vol. II, pp. 2189-2262. New York: Oxford University Press, 1992.
32. al-Sheyyab, N., Worthington, D., Beetham, R., and Stevens, M. The assessment of sub-clinical ifosfamide-induced renal tubular toxicity using urinary excretion of retinol binding protein. Pediatr. Hematol. Oncol., 10: 119-128, 1993.
33. Hale, D. E., and Bennett, M. J. Fatty acid oxidation disorders: a new class of metabolic diseases. J. Paediatr., 121: 1-11, 1992.
34. Goodmen, S. I., and Frerman, F. Glutaric aciduria type II and defects of the mitochondrial respiratory chain. In: C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (eds.), The Metabolic Basis of Inherited Disease, 6th Ed., pp. 915-931. New York: McGraw-Hill, 1989.
35. Passi, S., Picardo, M., De Luca, C., Nazzaro-Porro, M., Rossi, L., and Rotilo, G. Saturated dicarboxylic acids as products of unsaturated fatty acid oxidation. Biochim. Biophys. Acta, 1168: 190-198, 1993.
36. Sood, C., and O'Brien, P. J. Molecular mechanisms of chloroacetaldehyde-induced cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol., 46: 1621-1626, 1993.